Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class II · Moderate risk

Estradiol

cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.

Terminated Particulate / foreign matter B & B Pharmaceuticals, Inc. NDC 63275-9900-8 D-1244-2020
Class II · Moderate risk

Levothyroxin

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1228-2020
Class II · Moderate risk

Bi-Est (8:2)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1218-2020
Class II · Moderate risk

Bi-Est (1:1)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1217-2020
Class II · Moderate risk

Bi-Est

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1216-2020
Class II · Moderate risk

Bi-Est (8:2)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1215-2020
Class II · Moderate risk

Bi-Est (50/50)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1214-2020
Class II · Moderate risk

Bi-Est (50/50)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1213-2020
Class II · Moderate risk

Bi-Est (1:1)

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1212-2020

Recalls by year